IP Library › Granted Patent US 11,013,827
Granted Patent B2
US 11,013,827 · App. 15/809,766 · Granted May 25, 2021

Microstructured haptotaxic implant

Inventors: Lukas Bluecher (Eurasberg, DE); Michael Milbocker (Holliston, MA)
Assignee: BVW Holding AG
A61L27/26A61F2/0077A61L27/48A61L27/50A61L27/56A61L27/58A61F2/0063A61F2002/0081A61F2002/0086A61F2250/0031A61F2250/0056A61L2400/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,013,827
App. No.
15/809,766
Granted
May 25, 2021
Kind
B2
Abstract

The invention relates to the field of tissue engineering and regenerative medicine, and particularly to a three-dimensional biomimetic tissue scaffold that exploits the use of three-dimensional print technology. Surface energy is controlled by precisely placing polymers with differing surface chemistry, and using surface texture and bulk composition to pattern absorbable and non-absorbable polymers for the purpose of promoting functional healing in a mammalian body.

Claims (16)

1. A three-dimensional matrix for tissue regeneration comprising:

a bioabsorbable layered structure having a surface pattern provided on one or more layers of the bioabsorbable layered structure, the bioabsorbable layered structure including at least a first biocompatible polymer and a second biocompatible polymer, wherein the at least first and second biocompatible polymers are bioabsorbable and arranged in an alternating pattern such that the at least first polymer is interlocked with the at least second polymer creating interlocking loops and the alternating pattern creates open voids therebetween for seeding of ingrowth of cells, the at least first and second biocompatible polymers being solid at temperatures below 36° C., and wherein the bioabsorbable layered structure comprises at least three distinct surface energies wherein each of the three distinct surface energies correlate to a spatial scale, the spatial scales comprising a macro scale, a meso scale, and a fine scale, the macro scale ranging from 50 microns to 1 mm, wherein the macro scale surface energy is obtained from the first polymer and the second polymer, wherein the first polymer includes a first surface energy, the second polymer includes a second surface energy, and wherein the first and second surface energies are different, the meso scale ranging from 1 micron to 50 microns, wherein the meso scale surface energy is obtained from the surface pattern disposed on at least one of the first or second polymers, and the fine scale being less than 1 micron, wherein the fine scale surface energy is obtained by variation of the molecular structure of at least one of the first or second polymer.

2. The matrix of claim 1 , wherein the at least first biocompatible polymer is hydrophobic and the at least second biocompatible polymer is hydrophilic.

3. The matrix of claim 1 , wherein the at least first biocompatible polymer is lipophilic and the at least second biocompatible polymer is hydrophilic.

4. The matrix of claim 1 , wherein the at least first and second biocompatible polymers are nanofibers.

5. A medical device comprising the matrix of claim 1 , wherein the matrix is disposed on an implantable layer such that the medical device comprises the matrix joined to an implantable layer.

6. The medical device of claim 5 , wherein the implantable layer and the matrix are bioabsorbable, and wherein the implantable layer bioabsorbs more rapidly than the matrix.

7. A three-dimensional matrix for tissue regeneration comprising:

a bioabsorbable layered structure having a surface pattern provided on one or more layers of the bioabsorbable layered structure, the bioabsorbable layered structure including at least a first biocompatible polymer and a second biocompatible polymer, wherein the at least first and second biocompatible polymers are bioabsorbable and arranged in an alternating pattern such that the at least first polymer is interlocked with the at least second polymer and the alternating pattern creates open voids therebetween, the at least first and second biocompatible polymers being solid at temperatures below 36° C., and wherein the bioabsorbable layered structure comprises at least three distinct surface energies wherein each of the three distinct surface energies correlate to a spatial scale, the spatial scales comprising a macro scale, a meso scale, and a fine scale, the macro scale ranging from 50 microns to 1 mm, wherein the macro scale surface energy is obtained from the first polymer and the second polymer, wherein the first polymer includes a first surface energy, the second polymer includes a second surface energy, and wherein the first and second surface energies are different, the meso scale ranging from 1 micron to 50 microns, wherein the meso scale surface energy is obtained from the surface pattern disposed on at least one of the first or second polymers, and the fine scale being less than 1 micron, wherein the fine scale surface energy is obtained by variation of the molecular structure of at least one of the first or second polymer.

8. The matrix of claim 7 , wherein the at least first biocompatible polymer is hydrophobic and the at least second biocompatible polymer is hydrophilic.

9. The matrix of claim 7 , wherein the at least first biocompatible polymer is lipophilic and the at least second biocompatible polymer is hydrophilic.

10. The matrix of claim 7 , wherein at least one of the at least first biocompatible polymer and second biocompatible polymer comprises a nanofiber.

11. The matrix of claim 8 , wherein the at least first biocompatible polymer comprises polypropylene, polycaprolactone, or polylactic acid, or combinations thereof.

12. The matrix of claim 8 , wherein the at least second biocompatible polymer comprises polyether urethane, polyester urethane, or polyhyaluronic acid, or combinations thereof.

13. The matrix of claim 1 , wherein the bioabsorbable layered structure further comprises a bioactive agent.

14. The matrix of claim 7 , wherein the bioabsorbable layered structure further comprises a bioactive agent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2019
From: BLUECHER, LUKAS; MILBOCKER, MICHAEL
To: BVW HOLDING AG
Reel/Frame 048942/0109 →
Continuity (3)
Continuation PCTUS2017003046 · May 1, 2017
Provisional Application 62330104 · Apr 30, 2016
Related Publication 20180147321A1 · May 31, 2018
Cited By (1)
US 12,446,884